Basic Information
Basic information for MIR9-3HG-216-13aa
Peptide Name MIR9-3HG-216-13aa
Genome Position chr15:89389295-89389333[+]
Species Human
Peptide Sequence MGSLSLRSSPSLL
Peptide Length 13
Unique No (MIR9-3HG-233-13aa,MIR9-3HG-246-13aa,MIR9-3HG-253-13aa)
Grand Average of Hydropathicity 0.5077
Relative Molecular Mass 1563.74
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000655914;MIR9-3HG-216
Transcript Length 1319
Coding Ability 0.3935
DNA Sequence Corresponding to Peptide ATGGGGAGCCTCTCCCTTCGCAGCTCACCGTCTCTTCTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :